Yeon Kyeong Shin

Title: Yeon Kyeong Shin: Innovator in Pharmaceutical Formulations

Introduction

Yeon Kyeong Shin is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable liquid preparations for antibodies. With a total of six patents to his name, Shin's work is pivotal in advancing medical treatments.

Latest Patents

Shin's latest patents include a stable liquid pharmaceutical formulation of an anti-influenza virus antibody. This formulation comprises an anti-influenza virus antibody or a mixture of different types of antibodies, along with a surfactant, a sugar or sugar derivative, and an amino acid. The formulation demonstrates excellent storage stability at various temperatures, making it suitable for multiple administration routes. Another notable patent is a stable liquid formula comprising an anti-TNFa antibody, an acetate buffer, glycine, and a surfactant. This formulation remains stable even with high antibody content and is designed for subcutaneous administration.

Career Highlights

Yeon Kyeong Shin is currently employed at Celltrion Inc., a leading biopharmaceutical company. His work focuses on developing innovative solutions that enhance the efficacy and stability of pharmaceutical products. His contributions have been instrumental in the company's advancements in antibody therapies.

Collaborations

Shin collaborates with talented colleagues, including Joon Won Lee and So Young Kim. Together, they work on various projects aimed at improving pharmaceutical formulations and addressing medical challenges.

Conclusion

Yeon Kyeong Shin's innovative work in pharmaceutical formulations has made a significant impact in the field. His patents reflect a commitment to enhancing treatment options for patients, showcasing the importance of research and development in healthcare.